Page last updated: 2024-08-24

plerixafor and Developmental Psychomotor Disorders

plerixafor has been researched along with Developmental Psychomotor Disorders in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barbiro, B; Ezra, A; Rabinovich-Nikitin, I; Rabinovich-Toidman, P; Solomon, B	1

Other Studies

1 other study(ies) available for plerixafor and Developmental Psychomotor Disorders

Article	Year
Chronic administration of AMD3100 increases survival and alleviates pathology in SOD1(G93A) mice model of ALS. Journal of neuroinflammation, 2016, 05-26, Volume: 13, Issue:1 Topics: Amyotrophic Lateral Sclerosis; Animals; Benzylamines; Calcium-Binding Proteins; Chemokine CCL2; Claudin-5; Cyclams; Cytokines; Disease Models, Animal; Gene Expression Regulation; Heterocyclic Compounds; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microfilament Proteins; Motor Neurons; Muscle Strength; Psychomotor Disorders; Receptors, CXCR4; Superoxide Dismutase; Zonula Occludens-1 Protein	2016

Article

Year

Chronic administration of AMD3100 increases survival and alleviates pathology in SOD1(G93A) mice model of ALS.

Journal of neuroinflammation, 2016, 05-26, Volume: 13, Issue:1

Topics: Amyotrophic Lateral Sclerosis; Animals; Benzylamines; Calcium-Binding Proteins; Chemokine CCL2; Claudin-5; Cyclams; Cytokines; Disease Models, Animal; Gene Expression Regulation; Heterocyclic Compounds; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microfilament Proteins; Motor Neurons; Muscle Strength; Psychomotor Disorders; Receptors, CXCR4; Superoxide Dismutase; Zonula Occludens-1 Protein

2016